Price T Rowe Associates Inc Regenxbio Inc. Transaction History

Price T Rowe Associates Inc

$869 Billion
Q3 2024

A detailed history of Price T Rowe Associates Inc transactions in Regenxbio Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 21,928 shares of RGNX stock, worth $167,091. This represents 0.0% of its overall portfolio holdings.

Number of Shares

21,928

Previous 21,100 3.92%

Holding current value

$167,091

Previous $247,000 6.48%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$10.49 - $14.39 $8,685 - $11,914	828 Added 3.92%	21,928 $231,000
Q2 2024 Aug 14, 2024	BUY	$11.51 - $21.53 $33,643 - $62,932	2,923 Added 16.08%	21,100 $247,000
Q1 2024 May 15, 2024	BUY	$12.17 - $24.61 $17,500 - $35,389	1,438 Added 8.59%	18,177 $383,000
Q4 2023 Feb 14, 2024	BUY	$12.89 - $20.82 $14,784 - $23,880	1,147 Added 7.36%	16,739 $301,000
Q3 2023 Nov 14, 2023	BUY	$16.46 - $19.99 $18,830 - $22,868	1,144 Added 7.92%	15,592 $257,000
Q2 2023 Aug 14, 2023	BUY	$17.23 - $21.71 $8,373 - $10,551	486 Added 3.48%	14,448 $289,000
Q1 2023 May 15, 2023	SELL	$18.08 - $24.55 $2.86 Million - $3.89 Million	-158,349 Reduced 91.9%	13,962 $265,000
Q4 2022 Feb 14, 2023	SELL	$20.4 - $24.73 $994,316 - $1.21 Million	-48,741 Reduced 22.05%	172,311 $3.91 Million
Q3 2022 Nov 14, 2022	BUY	$22.29 - $35.04 $25,544 - $40,155	1,146 Added 0.52%	221,052 $5.84 Million
Q2 2022 Aug 15, 2022	SELL	$19.35 - $35.04 $584,582 - $1.06 Million	-30,211 Reduced 12.08%	219,906 $5.43 Million
Q1 2022 May 16, 2022	SELL	$24.62 - $34.31 $1.55 Million - $2.17 Million	-63,139 Reduced 20.16%	250,117 $8.3 Million
Q4 2021 Feb 14, 2022	BUY	$30.19 - $40.28 $552,809 - $737,567	18,311 Added 6.21%	313,256 $10.2 Million
Q3 2021 Nov 15, 2021	BUY	$29.09 - $45.68 $428,437 - $672,775	14,728 Added 5.26%	294,945 $12.4 Million
Q2 2021 Aug 16, 2021	SELL	$32.46 - $40.48 $465,151 - $580,078	-14,330 Reduced 4.87%	280,217 $10.9 Million
Q1 2021 May 17, 2021	BUY	$33.61 - $49.95 $191,946 - $285,264	5,711 Added 1.98%	294,547 $10 Million
Q4 2020 Feb 16, 2021	BUY	$26.52 - $49.35 $7.66 Million - $14.3 Million	288,836 New	288,836 $13.1 Million

Others Institutions Holding RGNX

# of Institutions

196

Shares Held

43M

Call Options Held

104K

Put Options Held

478K

View Full List

About REGENXBIO Inc.

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $329M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

More about RGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Regenxbio Inc. Transaction History